PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3570

  1. 832 Posts.
    lightbulb Created with Sketch. 331
    Surely you would think that they will release the 008 results just prior to the conference so that they are in the public domain and then PAR are free to comment / elaborate at the conference. They never know how many shareholders maybe in the audience. Mozz if the report drops maybe you could hand out a copy to all the Fan Club BP members?

    The Pool
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.